Net income · 2011–2025
Elite Pharmaceuticals net income
$44.9M+$49.2M · FY2025
Elite Pharmaceuticals (ELTP) reported $44.9M in net income for fiscal 2025, +$49.2M from the year before.
| Fiscal year | Net income | Change | Filing |
|---|---|---|---|
| FY20252026-03-31 | $44.9M | +$49.2M | Open → |
| FY20242025-03-31 | −$4.3M | −$24.4M | Open → |
| FY20232024-03-31 | $20.1M | +464.6% | Open → |
| FY20222023-03-31 | $3.6M | −60.0% | Open → |
| FY20212022-03-31 | $8.9M | +74.9% | Open → |
| FY20202021-03-31 | $5.1M | +$7.3M | Open → |
| FY20192020-03-31 | −$2.2M | +$7.0M | Open → |
| FY20182019-03-31 | −$9.3M | −$5.6M | Open → |
| FY20172018-03-31 | −$3.7M | −$7.5M | Open → |
| FY20162017-03-31 | $3.8M | +$4.5M | Open → |
| FY20152016-03-31 | −$683,012 | −$5.9M | Open → |
| FY20142015-03-31 | $5.2M | +$46.5M | Open → |
| FY20132014-03-31 | −$41.3M | −$42.7M | Open → |
| FY20122013-03-31 | $1.5M | +$16.5M | Open → |
| FY20112012-03-31 | −$15.1M | — | Open → |
Net income — Net income is profit after tax and all expenses, as reported in the annual filing. Companies reporting a loss are excluded from this ranking.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Net income at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Elite Pharmaceuticals net income |url=https://companiesranked.com/en/company/elite-pharmaceuticals/net-income |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Elite Pharmaceuticals net income. CompaniesRanked. https://companiesranked.com/en/company/elite-pharmaceuticals/net-incomeBibTeX
@misc{companiesranked-en-company-elite-pharmaceuticals-net-income-2026,
author = {{CompaniesRanked}},
title = {{Elite Pharmaceuticals net income}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/elite-pharmaceuticals/net-income}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001493152-26-031070 · June 29, 2026
{{cite web |title=Elite Pharmaceuticals net income — 10-K (0001493152-26-031070) |url=https://www.sec.gov/Archives/edgar/data/1053369/000149315226031070/form10-k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-06-29}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.